Industry news
Isis Pharma changes its name to Ionis Pharmaceuticals Inc
Isis Pharmaceuticals announced that the company has changed its name to Ionis Pharmaceuticals, an original name that the company has chosen to represent its innovative culture and heritage in the RNA-targeted therapeutic space for the past 26 years. Ionis is focused on bringing its late-stage Phase III drugs, nusinersen, volanesorsen and IONIS-TTRRx to the market and advancing its pipeline of high value drugs that have the potential to treat patients with life-threatening or serious diseases.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
